CT-011, a monoclonal PD-1 blocking antibody, enhances natural killer cell activation and cytotoxicity against multiple myeloma

被引:0
|
作者
Benson, Don
Chandler, Jason
Mishra, Anjali
Baiocchi, Robert
Yu, Jianhua
Liu, Tom
Lozanski, Gerard
Porcu, Pierluigi
Devine, Steven
Rotem-Yehudar, Rinat
Caligiuri, Michael
机构
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Curetech, Yavne, Israel
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5655
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Blocking the PD-1/PD-L1 axis in dendritic cell-stimulated Cytokine-Induced Killer Cells with pembrolizumab enhances their therapeutic effects against hepatocellular carcinoma
    Zhang, Wan
    Song, Zhenghui
    Xiao, Jianpeng
    Liu, Xinhui
    Luo, Yue
    Yang, Zike
    Luo, Rongcheng
    Li, Aimin
    JOURNAL OF CANCER, 2019, 10 (11): : 2578 - 2587
  • [22] Suppressing PD-L1 Expression via AURKA Kinase Inhibition Enhances Natural Killer Cell-Mediated Cytotoxicity against Glioblastoma
    Nguyen, Trang T. T.
    Gao, Qiuqiang
    Mun, Jeong-Yeon
    Zhu, Zhe
    Shu, Chang
    Naim, Aaron
    Rogava, Meri
    Izar, Benjamin
    Westhoff, Mike-Andrew
    Karpel-Massler, Georg
    Siegelin, Markus D.
    CELLS, 2024, 13 (13)
  • [23] The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function
    Allison L. Balasko
    Monika M. Kowatsch
    Colin Graydon
    Julie Lajoie
    Keith R. Fowke
    Scientific Reports, 13
  • [24] The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function
    Balasko, Allison L.
    Kowatsch, Monika M.
    Graydon, Colin
    Lajoie, Julie
    Fowke, Keith R.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [25] Transfection of chimeric anti-CD 138 gene enhances natural killer cell activation and killing of multiple myeloma cells
    Jiang, Hua
    Zhang, Wenhao
    Shang, Peipei
    Zhang, Hui
    Fu, Weijun
    Ye, Fei
    Zeng, Tianmei
    Huang, Hejing
    Zhang, Xueguang
    Sun, Wanping
    Sze, Daniel Man-Yuen
    Yi, Qing
    Hou, Jian
    MOLECULAR ONCOLOGY, 2014, 8 (02) : 297 - 310
  • [26] The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint Pathway
    Fantini, Massimo
    David, Justin M.
    Annunziata, Christina M.
    Morelli, Maria Pia
    Arlen, Phillip M.
    Tsang, Kwong Y.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2020, 35 (03) : 190 - 198
  • [27] PD-L1/PD-1 blockage enhanced the cytotoxicity of natural killer cell on the non-small cell lung cancer (NSCLC) by granzyme B secretion
    Duan-Rui Qiao
    Jun-Ya Cheng
    Wei-Qun Yan
    Hai-Jun Li
    Clinical and Translational Oncology, 2023, 25 : 2373 - 2383
  • [28] PD-L1/PD-1 blockage enhanced the cytotoxicity of natural killer cell on the non-small cell lung cancer (NSCLC) by granzyme B secretion
    Qiao, Duan-Rui
    Cheng, Jun-Ya
    Yan, Wei-Qun
    Li, Hai-Jun
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (08): : 2373 - 2383
  • [29] The Humanized Anti PD-1 Antibody, CT-011, Increases Specific CD4+Effector/Memory and Memory T Lymphocytes in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Following Autologous Stem Cell Transplantation (AuSCT).
    Rotem-Yehudar, Rinat
    Armand, Philippe
    Devine, Steve
    Fay, Joseph W.
    Hosing, Chitra
    Mapara, Markus Y.
    Campagnero, Erica
    Uberti, Joseph P.
    Avigan, David
    Ballen, Karen K.
    Winter, Jane N.
    Nagler, Arnon
    Gordon, Leo I.
    BLOOD, 2009, 114 (22) : 500 - 501
  • [30] Targeting Caveolin-1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell-Mediated Immunotherapy
    Zhan, Dewen
    Du, Zhimin
    Zhang, Shang
    Huang, Juanru
    Zhang, Jian
    Zhang, Hui
    Liu, Zhongrui
    Menu, Eline
    Wang, Jinheng
    ADVANCED SCIENCE, 2025, 12 (04)